Carlos Zaragoza
Overview
Explore the profile of Carlos Zaragoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valdecantos M, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, et al.
Nat Commun
. 2024 Nov;
15(1):10342.
PMID: 39609390
Bariatric surgery is effective for the treatment and remission of obesity and type 2 diabetes, but pharmacological approaches which exert similar metabolic adaptations are needed to avoid post-surgical complications. Here...
2.
Kleinbongard P, Arriola C, Badimon L, Crisostomo V, Giricz Z, Gyongyosi M, et al.
Basic Res Cardiol
. 2024 Oct;
119(6):893-909.
PMID: 39422732
Numerous cardioprotective interventions have been reported to reduce myocardial infarct size (IS) in pre-clinical studies. However, their translation for the benefit of patients with acute myocardial infarction (AMI) has been...
3.
Hernandez-Navarro I, Botana L, Diez-Mata J, Tesoro L, Jimenez-Guirado B, Gonzalez-Cucharero C, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337378
Vascular aging is associated with the development of cardiovascular complications, in which endothelial cell senescence (ES) may play a critical role. Nitric oxide (NO) prevents human ES through inhibition of...
4.
Hinojar R, Moreno-Gomez-Toledano R, Conde E, Gonzalez-Gomez A, Garcia-Martin A, Gonzalez-Portilla P, et al.
ESC Heart Fail
. 2024 Apr;
11(4):2272-2286.
PMID: 38638083
Aim: Severe functional tricuspid regurgitation (FTR) is associated with high risk of cardiovascular events, particularly heart failure (HF) and mortality. MicroRNAs (miRNAs) have been recently identified as novel biomarkers in...
5.
Tesoro L, Hernandez I, Saura M, Badimon L, Zaragoza C
Eur J Clin Invest
. 2024 Apr;
54(7):e14208.
PMID: 38622800
Background: Cardiovascular diseases (CVD) impact a substantial portion of the global population and represent a significant threat to experiencing life-threatening outcomes, such as atherosclerosis, myocardial infarction, stroke and heart failure....
6.
Delgado-Marin M, Sanchez-Esteban S, Cook-Calvete A, Jorquera-Ortega S, Zaragoza C, Saura M
Cells
. 2024 Mar;
13(6.
PMID: 38534325
Calcific Aortic Valve Disease (CAVD) is a significant concern for cardiovascular health and is closely associated with chronic kidney disease (CKD). Aortic valve endothelial cells (VECs) play a significant role...
7.
Ramirez-Carracedo R, Hernandez I, Moreno-Gomez-Toledano R, Diez-Mata J, Tesoro L, Gonzalez-Cucharero C, et al.
J Hypertens
. 2024 Feb;
42(4):685-693.
PMID: 38406874
Background: Endothelial nitric oxide synthase (NOS3) elicits atheroprotection by preventing extracellular matrix (ECM) proteolytic degradation through inhibition of extracellular matrix metalloproteinase inducer (EMMPRIN) and collagenase MMP-13 by still unknown mechanisms....
8.
Moreno-Gomez-Toledano R, Delgado-Marin M, Cook-Calvete A, Gonzalez-Cucharero C, Alcharani N, Jimenez-Guirado B, et al.
World J Diabetes
. 2023 Sep;
14(8):1301-1313.
PMID: 37664470
Background: Diabetes mellitus (DM) is one of the largest global health emergencies of the 21st century. In recent years, its connection with environmental pollutants, such as bisphenol A (BPA), has...
9.
Paz-Garcia M, Povo-Retana A, Jaen R, Prieto P, Peraza D, Zaragoza C, et al.
Biomed Pharmacother
. 2023 Mar;
158:114214.
PMID: 36916435
Experimental evidence indicates that the control of the inflammatory response after myocardial infarction is a key strategy to reduce cardiac injury. Cellular damage after blood flow restoration in the heart...
10.
Diaz Del Campo L, Garcia-Redondo A, Rodriguez C, Zaragoza C, Duro-Sanchez S, Palmas F, et al.
Hypertension
. 2022 Nov;
80(1):84-96.
PMID: 36337053
Background: Resolution of inflammation is orchestrated by specialized proresolving lipid mediators (SPMs), and this would be impaired in some cardiovascular diseases. Among SPMs, resolvins (Rv) have beneficial effects in cardiovascular...